These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018. Malinis M, La Hoz RM, Vece G, Annambhotla P, Aslam S, Basavaraju SV, Bucio J, Danziger-Isakov L, Florescu DF, Jones JM, Rana M, Wolfe CR, Michaels MG. Transpl Infect Dis; 2022 Apr; 24(2):e13800. PubMed ID: 35064737 [Abstract] [Full Text] [Related]
3. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country. Kwon DE, Han SH, Han KD, La Y, Lee KH. Transpl Infect Dis; 2021 Dec; 23(6):e13729. PubMed ID: 34505751 [Abstract] [Full Text] [Related]
4. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, Cervera C, Len O, Carratala J, Cisneros JM, Bou G, Muñoz P, Ramos A, Gurgui M, Borrell N, Fortún J, Moreno A, Gavalda J, Spanish Network for Research in Infectious Diseases. Clin Infect Dis; 2009 Jun 15; 48(12):1657-65. PubMed ID: 19445585 [Abstract] [Full Text] [Related]
5. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Sidhu A, Verma G, Humar A, Kumar D. Transplantation; 2014 Sep 27; 98(6):671-5. PubMed ID: 24825525 [Abstract] [Full Text] [Related]
14. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population-based cohort study. Hosseini-Moghaddam SM, Ouédraogo A, Naylor KL, Bota SE, Husain S, Nash DM, Paterson JM. Transpl Infect Dis; 2020 Apr 27; 22(2):e13250. PubMed ID: 31981389 [Abstract] [Full Text] [Related]
15. Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan. Chiang CY, Chen CH, Feng JY, Chiang YJ, Huang WC, Lin YJ, Huang YW, Wu HH, Lee PH, Lee MC, Shu CC, Wang HH, Wang JY, Wu MY, Lee CY, Wu MS. J Formos Med Assoc; 2023 Oct 27; 122(10):976-985. PubMed ID: 37183074 [Abstract] [Full Text] [Related]
16. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients. Hosseini-Moghaddam SM, Luo B, Bota SE, Husain S, Silverman MS, Daneman N, Brown KA, Paterson JM. JAMA Netw Open; 2021 Dec 01; 4(12):e2141089. PubMed ID: 34964852 [Abstract] [Full Text] [Related]
17. Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Propensity-matched Analysis of a Large Research Network. Hadi YB, Naqvi SFZ, Kupec JT, Sofka S, Sarwari A. Transplantation; 2021 Jun 01; 105(6):1365-1371. PubMed ID: 33988341 [Abstract] [Full Text] [Related]
19. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients. Ha YE, Joo EJ, Park SY, Wi YM, Kang CI, Chung DR, Joh JW, Lee SK, Song JH, Peck KR. Transpl Infect Dis; 2012 Dec 01; 14(6):626-34. PubMed ID: 22372581 [Abstract] [Full Text] [Related]
20. Mycobacterium tuberculosis-associated immune reconstitution syndrome in solid-organ transplant recipients. Sun HY, Munoz P, Torre-Cisneros J, Aguado JM, Lattes R, Montejo M, Garcia-Reyne A, Bouza E, Valerio M, Lara R, John GT, Bruno D, Singh N. Transplantation; 2013 May 15; 95(9):1173-81. PubMed ID: 23435454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]